On the contrary, Pillai et al. have reported that both exogenous visfatin/Nampt and visfatin/Nampt overexpressions promote cardiac hypertrophy and adverse ventricular remodeling [94]. The gene discussed is NAMPT; the disease is cardiac hypertrophy.